| Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse JP Gisbert, F Bermejo, JL Pérez-Calle, C Taxonera, I Vera, AG McNicholl, ... Inflammatory bowel diseases 15 (8), 1190-1198, 2009 | 425 | 2009 |
| Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of Helicobacter pylori infection AG McNicholl, PM Linares, OP Nyssen, X Calvet, JP Gisbert Alimentary pharmacology & therapeutics 36 (5), 414-425, 2012 | 360 | 2012 |
| Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease JP Gisbert, AG McNicholl Digestive and Liver Disease 41 (1), 56-66, 2009 | 353 | 2009 |
| Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed JP Gisbert, AC Marín, AG McNicholl, M Chaparro Alimentary pharmacology & therapeutics 41 (7), 613-623, 2015 | 347 | 2015 |
| Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis JP Gisbert, PM Linares, AG McNicholl, J Maté, F Gomollón Alimentary pharmacology & therapeutics 30 (2), 126-137, 2009 | 294 | 2009 |
| IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori JP Gisbert, J Molina-Infante, J Amador, F Bermejo, L Bujanda, X Calvet, ... Gastroenterología y Hepatología 39 (10), 697-721, 2016 | 198* | 2016 |
| Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice AG McNicholl, AC Marin, J Molina-Infante, M Castro, J Barrio, J Ducons, ... Gut 63 (2), 244-249, 2014 | 184 | 2014 |
| Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement JP Gisbert, F Bermejo, R Pajares, JL Perez-Calle, M Rodríguez, A Algaba, ... Inflammatory bowel diseases 15 (10), 1485-1491, 2009 | 171 | 2009 |
| Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease JP Gisbert, AG McNicholl, F Gomollon Inflammatory bowel diseases 15 (11), 1746-1754, 2009 | 153 | 2009 |
| Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth … JP Gisbert, M Romano, AG Gravina, P Solís‐Muñoz, F Bermejo, ... Alimentary pharmacology & therapeutics 41 (8), 768-775, 2015 | 151 | 2015 |
| Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies JP Gisbert, AG McNicholl Helicobacter 22 (4), e12392, 2017 | 144 | 2017 |
| A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication) AC Marin, AG McNicholl, JP Gisbert Expert opinion on pharmacotherapy 14 (7), 843-861, 2013 | 133 | 2013 |
| III Spanish consensus conference on Helicobacter pylori infection JP Gisbert, X Calvet, F Bermejo, D Boixeda, F Bory, L Bujanda, ... Gastroenterologia y hepatologia 36 (5), 340-374, 2013 | 122* | 2013 |
| Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study J Molina‐Infante, AJ Lucendo, T Angueira, M Rodriguez‐Tellez, ... Alimentary pharmacology & therapeutics 41 (6), 581-589, 2015 | 120 | 2015 |
| Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients AG McNicholl, DS Bordin, A Lucendo, G Fadeenko, MC Fernandez, ... Clinical Gastroenterology and Hepatology 18 (1), 89-98, 2020 | 118 | 2020 |
| Sequential versus standard triple first‐line therapy for Helicobacter pylori eradication OP Nyssen, AG McNicholl, F Megraud, V Savarino, G Oderda, CA Fallone, ... Cochrane Database of Systematic Reviews, 2016 | 111 | 2016 |
| Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients Y González‐Lama, F Bermejo, A López‐Sanromán, V García‐Sánchez, ... Alimentary pharmacology & therapeutics 34 (5), 544-554, 2011 | 99 | 2011 |
| Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori OP Nyssen, AG McNicholl, JP Gisbert Helicobacter 24 (2), e12570, 2019 | 86 | 2019 |
| Accuracy of GastroPanel for the diagnosis of atrophic gastritis AG McNicholl, M Forné, J Barrio, C De la Coba, B González, R Rivera, ... European journal of gastroenterology & hepatology 26 (9), 941-948, 2014 | 75 | 2014 |
| Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy JP Gisbert, J Barrio, I Modolell, J Molina-Infante, AP Aisa, ... Digestive diseases and sciences 60, 458-464, 2015 | 67 | 2015 |
Javier P. Gisbert (ORCID:0000-0003-2...Hospital de La Princesa; Instituto de Investigación Sanitaria Princesa (IIS-Princesa); UAM; CIBEREHDEmail verificata su uam.es
